Priscilla Kasenchak - 14 Apr 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Apr 2023, 16:46:24 UTC
Prior SEC filing
05 Oct 2022
Next SEC filing
25 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mimi Yang, as Attorney-in-Fact

Key filing fact

Priscilla Kasenchak filed Form 4 for agilon health, inc. (AGL) on 18 Apr 2023.

Key facts

  • This page summarizes Priscilla Kasenchak's Form 4 filing for agilon health, inc. (AGL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Apr 2023, 16:46.

Change

  • Previous filing in this sequence was filed on 05 Oct 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGL transaction

Common Stock

Award

Transaction value
$0
Shares
+4,393
Change %
+131%
Price
$0.000000
Shares after
7,745
Date
14 Apr 2023
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGL transaction Derivative

Options (Rights to Buy)

Award

Transaction value
$0
Shares
+7,595
Change %
Price
$0.000000
Shares after
7,595
Date
14 Apr 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,595
Exercise price
$28.46
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.

Footnote F2

Includes restricted stock units.

Footnote F3

Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.

SEC remarks

Exhibit List: Ex.24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .